TLPH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Talphera Inc (TLPH) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators are bearish, the financial performance shows significant losses, and there are no strong positive catalysts or trading signals to suggest immediate upside potential. A hold position is recommended until clearer bullish signals or stronger financial improvements emerge.
The technical indicators are bearish. The MACD is below zero and contracting negatively, RSI is neutral at 42.737, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 0.791, with key support at 0.724 and resistance at 0.857.
Talphera announced the acceptance of two research abstracts for presentation at a major nephrology conference, and the NEPHRO CRRT clinical study has achieved 50% enrollment. Additionally, the company closed a $4.1 million financing tranche, which may provide short-term operational support.
is also down 0.43%. Financial performance in Q4 2025 shows a net loss of $3.8 million, with no revenue growth. Technical indicators and trading sentiment are neutral to bearish, and there is no recent activity from insiders, hedge funds, or Congress.
In Q4 2025, Talphera reported a net loss of $3.8 million, with no revenue growth. EPS was -$0.06, which slightly beat expectations by $0.01. The company has a cash balance of $20.4 million, which may provide short-term liquidity but does not indicate strong financial health.
No data on analyst ratings or price target changes is available. Wall Street sentiment appears neutral with no significant pros or cons highlighted.
